GLSI   $14.88  -0.07% Market Closed After Close 14.845 -0.24%

Greenwich Lifesciences Inc
Total Cash 7.22M
totalCashPerShare 0.55
EBITDA -10.53M
Total Debt 0.00
quickRatio 5.34
currentRatio 5.34
Total Revenue
debtToEquity
Revenue/Share
ROA -0.72453004
ROE -1.2366999
grossProfits
freeCashflow -3.15M
operatingCashflow -6.79M
earningsGrowth
revenueGrowth
grossMargins 0.0
ebitdaMargins 0.0
operatingMargins 0.0
profitMargins 0.0
enterpriseValue 189.02M
forwardPE -17.720243
floatShares 5.93M
sharesOutstanding 13.14M
sharesShort 466.63K
sharesShortPriorMonth 415.62K
dateShortInterest
sharesPercentSharesOut 0.04%
heldPercentInsiders 0.54%
heldPercentInstitutions 0.09%
Short Ratio help_outline 17.13%
shortPercentOfFloat 0.07%
impliedSharesOutstanding
bookValue 0.45
Price To Book help_outline 32.29
earningsQuarterlyGrowth
netIncomeToCommon -10.22M
trailingEps -0.79%
forwardEps -0.82%
enterpriseToEbitda -17.94
lastDividendValue
lastDividendDate
currentQuarterEstimate -0.21 3Q 2024
institutionsCount 55
lastUpdated Sept. 16, 2024, 8:02 p.m.